| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/1535370213489441 |
| P698 | PubMed publication ID | 23856899 |
| P50 | author | Asish K Ghosh | Q91313744 |
| P2093 | author name string | Douglas E Vaughan | |
| Susan E Quaggin | |||
| P2860 | cites work | MicroRNAs as a therapeutic target for cardiovascular diseases | Q37294704 |
| Essential roles for early growth response transcription factor Egr-1 in tissue fibrosis and wound healing. | Q37316485 | ||
| TGF-beta signal transduction | Q22003891 | ||
| TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4 | Q24314661 | ||
| Transforming growth factor-beta (TGF-beta) | Q24321520 | ||
| Mutation of the mouse klotho gene leads to a syndrome resembling ageing | Q24328782 | ||
| Angiopoietin-1 is essential in mouse vasculature during development and in response to injury | Q24629743 | ||
| The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing | Q24633454 | ||
| MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue | Q24643939 | ||
| Cellular and molecular mechanisms of fibrosis | Q24648892 | ||
| Pathways of Egr-1-mediated gene transcription in vascular biology | Q24671655 | ||
| Regulation of endothelial cell plasticity by TGF-β | Q26862059 | ||
| Myofibroblasts | Q27022840 | ||
| Role of transforming growth factor beta in human disease | Q28143408 | ||
| The mechanisms of action of PPARs | Q28216953 | ||
| Transforming growth factor-beta regulates DNA binding activity of transcription factor Fli1 by p300/CREB-binding protein-associated factor-dependent acetylation | Q28249959 | ||
| Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling | Q28251743 | ||
| TGFβ signalling in context | Q28275410 | ||
| Augmented Wnt signaling in a mammalian model of accelerated aging | Q28506533 | ||
| MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts | Q28511032 | ||
| Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress | Q28512203 | ||
| Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis | Q28568441 | ||
| Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects | Q28570037 | ||
| Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in skin fibroblasts | Q28584045 | ||
| Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor | Q29547912 | ||
| Endothelial-to-mesenchymal transition contributes to cardiac fibrosis | Q29620566 | ||
| Inhibiting scar formation in vitro and in vivo by adenovirus-mediated mutant Smad4: a preliminary report | Q30273982 | ||
| Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney. | Q30499402 | ||
| Chemical phylogenetics of histone deacetylases | Q30977637 | ||
| MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis | Q33643242 | ||
| Resistance to bleomycin-induced lung fibrosis in MMP-8 deficient mice is mediated by interleukin-10 | Q33719352 | ||
| Peroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator | Q37326935 | ||
| Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. | Q37417291 | ||
| Fibroproliferative disorders. | Q37647584 | ||
| Shifting players and paradigms in cell-specific transcription | Q37671910 | ||
| Clinical Use of Interferon-gamma | Q37675044 | ||
| PAI-1 in tissue fibrosis | Q37861626 | ||
| Non-Smad signaling pathways | Q37893980 | ||
| Klotho in health and disease | Q38015713 | ||
| Wound repair and regeneration | Q38026474 | ||
| MicroRNAs, transforming growth factor beta-1, and tissue fibrosis. | Q38050081 | ||
| Inflammation, wound repair, and fibrosis: reassessing the spectrum of tissue injury and resolution | Q38055448 | ||
| Histone lysine methylation dynamics: establishment, regulation, and biological impact | Q38064095 | ||
| Blocking sp1 transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: implications for the treatment of tissue fibrosis | Q38300936 | ||
| The early-immediate gene EGR-1 is induced by transforming growth factor-beta and mediates stimulation of collagen gene expression | Q38313294 | ||
| Ring-Sp1 decoy oligonucleotide effectively suppresses extracellular matrix gene expression and fibrosis of rat kidney induced by unilateral ureteral obstruction | Q38317847 | ||
| Inhibition of collagen gene expression by interferon-gamma: novel role of the CCAAT/enhancer binding protein beta (C/EBPbeta). | Q38318024 | ||
| Anti-fibrotic effects via regulation of transcription factor Sp1 on hepatic stellate cells | Q38326907 | ||
| Effects of angiotensin II receptor blocker on myocardial endothelial-to-mesenchymal transition in diabetic rats | Q38333959 | ||
| Antifibrotic effect through the regulation of transcription factor using ring type-Sp1 decoy oligodeoxynucleotide in carbon tetrachloride-induced liver fibrosis | Q38352858 | ||
| Anti-inflammatory and antifibrotic effects of methyl palmitate | Q39541716 | ||
| Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion | Q39554276 | ||
| Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes | Q39690407 | ||
| Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis | Q39713121 | ||
| TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. | Q39737677 | ||
| Trichostatin A inhibits TGF-β1 induced in vitro chondrogenesis of hMSCs through Sp1 suppression | Q39817587 | ||
| Snail is required for TGFbeta-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells | Q39939184 | ||
| Nicotinamide induces apoptosis and reduces collagen I and pro-inflammatory cytokines expression in rat hepatic stellate cells | Q40373054 | ||
| Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53 | Q40395907 | ||
| TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300 | Q40445183 | ||
| S-adenosylmethionine (AdoMet) modulates endotoxin stimulated interleukin-10 production in monocytes | Q40649351 | ||
| Introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial alpha-smooth muscle actin expression and fibrosis in unilateral ureteral obstruction (UUO) rats | Q40738851 | ||
| Changes in p53 expression in mouse fibroblasts can modify motility and extracellular matrix organization. | Q40835991 | ||
| Sp1 is required for the early response of alpha2(I) collagen to transforming growth factor-beta1. | Q41094631 | ||
| Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation | Q41774831 | ||
| The induction of CCN2 by TGFbeta1 involves Ets-1. | Q41849541 | ||
| Modulation of human alpha1(I) procollagen gene activity by interaction with Sp1 and Sp3 transcription factors in vitro | Q42458261 | ||
| Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma | Q42459998 | ||
| The tumor suppressor p53 abrogates Smad-dependent collagen gene induction in mesenchymal cells | Q42466997 | ||
| CCL18-stimulated upregulation of collagen production in lung fibroblasts requires Sp1 signaling and basal Smad3 activity | Q42481241 | ||
| Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators | Q42491309 | ||
| Proteasome inhibition reduces proliferation, collagen expression, and inflammatory cytokine production in nasal mucosa and polyp fibroblasts. | Q42509474 | ||
| Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis | Q42516749 | ||
| Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation | Q42518271 | ||
| Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT. | Q42590202 | ||
| Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition | Q42775592 | ||
| Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor beta1 stimulation of alpha 2(I)-collagen (COL1A2) transcription | Q42795742 | ||
| Connective tissue growth factor is induced in bleomycin-induced skin scleroderma | Q42917225 | ||
| Sodium valproate, a histone deacetylase inhibitor, but not captopril, prevents right ventricular hypertrophy in rats. | Q43140361 | ||
| Transcription factor Sp1 expression is upregulated in human glomerulonephritis: correlation with pSmad2/3 and p300 expression and renal injury | Q43144139 | ||
| Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury | Q43244113 | ||
| Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride. | Q43877873 | ||
| Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice | Q43882371 | ||
| Troglitazone suppresses the secretion of type I collagen by mesangial cells in vitro. | Q43936714 | ||
| Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. | Q44021747 | ||
| IL-18 downregulates collagen production in human dermal fibroblasts via the ERK pathway | Q44397955 | ||
| Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats | Q44507331 | ||
| Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats | Q44963004 | ||
| Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes | Q45054700 | ||
| Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program | Q45184208 | ||
| Antifibrotic effect of interferon gamma in silicosis model of rat. | Q45223247 | ||
| Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model | Q45862411 | ||
| Antifibrotic effect via the regulation of transcription factor Sp1 in lung fibrosis | Q45871071 | ||
| Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelial-mesenchymal transition | Q45877659 | ||
| Egr-1, the potential target of calcium channel blockers in cardioprotection with ischemia/reperfusion injury in rats. | Q45933449 | ||
| Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice. | Q46021850 | ||
| Tomio Tada 1934-2010. | Q48461688 | ||
| Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro. | Q52617872 | ||
| Characterization of the phenotype of high collagen-producing fibroblast clones in systemic sclerosis, using a new modified limiting-dilution method. | Q53169053 | ||
| Transforming growth factor-β-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21. | Q53398171 | ||
| Trichostatin A blocks TGF-beta-induced collagen gene expression in skin fibroblasts: involvement of Sp1. | Q53576576 | ||
| Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-beta signaling and endothelial-to-mesenchymal transition. | Q54412343 | ||
| Sp1 and Sp3 transcription factors mediate leptin-induced collagen α1(I) gene expression in primary culture of male rat hepatic stellate cells. | Q54475608 | ||
| Effects of N-n-butyl haloperidol iodide on myocardial ischemia/reperfusion injury and Egr-1 expression in rat. | Q54597915 | ||
| Postconditioning promotes the cardiac repair through balancing collagen degradation and synthesis after myocardial infarction in rats | Q56534241 | ||
| A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture | Q57228777 | ||
| PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis | Q33745028 | ||
| Macrophages produce TGF-beta-induced (beta-ig-h3) following ingestion of apoptotic cells and regulate MMP14 levels and collagen turnover in fibroblasts | Q33760755 | ||
| TGF-beta and fibrosis | Q33804142 | ||
| Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice | Q33853415 | ||
| Hepatic fibrosis is enhanced and accompanied by robust oval cell activation after chronic carbon tetrachloride administration to Egr-1-deficient mice | Q33882433 | ||
| Tumor suppressor p53: regulation and function | Q33890466 | ||
| Transcriptional regulation of matrix metalloproteinase-1 and collagen 1A2 explains the anti-fibrotic effect exerted by proteasome inhibition in human dermal fibroblasts | Q33923496 | ||
| Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy | Q33929939 | ||
| Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease | Q33942130 | ||
| Deficient Smad7 expression: a putative molecular defect in scleroderma | Q34021184 | ||
| p53 at a glance | Q34029735 | ||
| Aging mechanisms | Q34062964 | ||
| PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer | Q34106716 | ||
| miR-192 mediates TGF-beta/Smad3-driven renal fibrosis | Q34124178 | ||
| Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro | Q34170852 | ||
| MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma | Q34252230 | ||
| Tumor necrosis factor-alpha and interferon-gamma suppress the activation of human type I collagen gene expression by transforming growth factor-beta 1. Evidence for two distinct mechanisms of inhibition at the transcriptional and posttranscriptional | Q34263054 | ||
| Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression | Q34371002 | ||
| An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. | Q34378178 | ||
| Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats | Q34414756 | ||
| Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice | Q34514594 | ||
| Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF.κB-dependent mechanisms in mice. | Q34542559 | ||
| Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice | Q34624546 | ||
| The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis | Q34636005 | ||
| In preeclampsia endogenous cardiotonic steroids induce vascular fibrosis and impair relaxation of umbilical arteries | Q34647825 | ||
| New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis | Q34720147 | ||
| Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis | Q34805635 | ||
| Early growth response (EGR)-1 is required for timely cell-cycle entry and progression in hepatocytes after acute carbon tetrachloride exposure in mice. | Q35057036 | ||
| Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma | Q35102837 | ||
| Interleukin-10 therapy--review of a new approach | Q35139563 | ||
| Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator-activated receptor-gamma | Q35170133 | ||
| The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation | Q35205960 | ||
| Identification of a microRNA signature in renal fibrosis: role of miR-21. | Q35326035 | ||
| Myocardin-related transcription factor-A complexes activate type I collagen expression in lung fibroblasts. | Q35626103 | ||
| Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases | Q35649473 | ||
| Distinctive role of Stat3 and Erk-1/2 activation in mediating interferon-gamma inhibition of TGF-beta1 action | Q35677699 | ||
| Therapeutic value of small molecule inhibitor to plasminogen activator inhibitor-1 for lung fibrosis | Q35684759 | ||
| Nuclear β-catenin is increased in systemic sclerosis pulmonary fibrosis and promotes lung fibroblast migration and proliferation | Q35684848 | ||
| Leptin promotes fibroproliferative acute respiratory distress syndrome by inhibiting peroxisome proliferator-activated receptor-γ | Q35694487 | ||
| p300/CBP and cancer | Q35779695 | ||
| Early growth response factor-1 limits biliary fibrosis in a model of xenobiotic-induced cholestasis in mice | Q35787690 | ||
| Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin | Q35791840 | ||
| The p53 inhibitor pifithrin-α can stimulate fibrosis in a rat model of ischemic acute kidney injury. | Q35924490 | ||
| HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. | Q35968237 | ||
| Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure | Q35968905 | ||
| Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas. | Q36048656 | ||
| Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice | Q36089631 | ||
| Transcription initiation by human RNA polymerase II visualized at single-molecule resolution | Q36162657 | ||
| Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB | Q36174897 | ||
| CD11b(+) Gr1(+) bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in mice | Q36188234 | ||
| Canonical Wnt/β-catenin signaling in epicardial fibrosis of failed pediatric heart allografts with diastolic dysfunction. | Q36189271 | ||
| CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor beta transcriptional responses in endothelial cells | Q36263679 | ||
| The many faces of PPARgamma | Q36344625 | ||
| Plasma klotho and cardiovascular disease in adults | Q36364310 | ||
| Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis | Q36399732 | ||
| Curcumin promotes cardiac repair and ameliorates cardiac dysfunction following myocardial infarction | Q36446530 | ||
| Transforming growth factor-beta and the immune system | Q36457999 | ||
| Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling | Q36494436 | ||
| p53 is renoprotective after ischemic kidney injury by reducing inflammation. | Q36509298 | ||
| Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells | Q36558691 | ||
| Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs | Q36673667 | ||
| Proteasomal inhibition after injury prevents fibrosis by modulating TGF-β(1) signalling | Q36678523 | ||
| p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-β: epigenetic feed-forward amplification of fibrosis. | Q36767089 | ||
| Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. | Q36769644 | ||
| Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin | Q37071681 | ||
| Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma | Q37071874 | ||
| Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy | Q37190292 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 461-481 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | Experimental Biology and Medicine | Q15716535 |
| P1476 | title | Molecular basis of organ fibrosis: potential therapeutic approaches | |
| P478 | volume | 238 |
| Q49533762 | A novel acetyltransferase p300 inhibitor ameliorates hypertension-associated cardio-renal fibrosis. |
| Q64279546 | Acetyltransferase p300 inhibitor reverses hypertension-induced cardiac fibrosis |
| Q35113804 | Activation of non-canonical TGF-β1 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis |
| Q34984781 | Adoptive transfer of regulatory T cells protects against Coxsackievirus B3-induced cardiac fibrosis |
| Q30405346 | Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways |
| Q48506246 | Balancing effect of Biejiajian Oral Liquid () on ACE-Ang II-AT1R axis and ACE2-Ang-(1-7)-Mas axis in rats with CCl4-induced hepatic fibrosis |
| Q58576263 | Comparative Expression of Renin-Angiotensin Pathway Proteins in Visceral Versus Subcutaneous Fat |
| Q27011803 | Decellularized matrices for cardiovascular tissue engineering |
| Q45072634 | Diabetic Microvascular Disease: An Endocrine Society Scientific Statement |
| Q38779316 | Electrostatic and Hydrophobic Interactions Mediate Single-Stranded DNA Recognition and Acta2 Repression by Purine-Rich Element-Binding Protein B. |
| Q48285933 | Emerging role of Twist1 in fibrotic diseases |
| Q54982965 | Endothelial to Mesenchymal Transition Represents a Key Link in the Interaction between Inflammation and Endothelial Dysfunction. |
| Q36113039 | Epigenetics and the overhealing wound: the role of DNA methylation in fibrosis |
| Q38163413 | Epigenetics in immune-mediated pulmonary diseases |
| Q96618200 | Evidence for endothelial-to-mesenchymal transition in human brain arteriovenous malformations |
| Q52945736 | Expression of Smad7 and Smad ubiquitin regulatory factor 2 in a rat model of chronic pancreatitis. |
| Q51592018 | FGF2 Overrides TGFβ1-Driven Integrin ITGA11 Expression in Human Dermal Fibroblasts. |
| Q90337889 | Fibronectin has multifunctional roles in posterior capsular opacification (PCO) |
| Q50420630 | Genome-wide strategies identify downstream target genes of connective tissue-associated transcription factors. |
| Q90147211 | Ginsenoside Rg3 protects against iE-DAP-induced endothelial-to-mesenchymal transition by regulating the miR-139-5p-NF-κB axis |
| Q59791979 | Glutamyl-Prolyl-tRNA Synthetase Regulates Epithelial Expression of Mesenchymal Markers and Extracellular Matrix Proteins: Implications for Idiopathic Pulmonary Fibrosis |
| Q38282776 | Klotho and renal fibrosis |
| Q33731819 | MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis |
| Q34987622 | MicroRNA miR145 regulates TGFBR2 expression and matrix synthesis in vascular smooth muscle cells |
| Q64098640 | MicroRNA-152-5p inhibits proliferation and migration and promotes apoptosis by regulating expression of Smad3 in human keloid fibroblasts |
| Q49896916 | MicroRNAs as Critical Regulators of the Endothelial to Mesenchymal Transition in Vascular Biology. |
| Q38161422 | Modifiers of heart and muscle function: where genetics meets physiology |
| Q35837331 | Myocardin-related Transcription Factor Regulates Nox4 Protein Expression: LINKING CYTOSKELETAL ORGANIZATION TO REDOX STATE. |
| Q37541098 | NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses. |
| Q35805769 | Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice |
| Q45868567 | Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis |
| Q64970542 | Potential Effect of Cyclophosphamide on Bleb Survival in Five Patients with Multiple Sclerosis Who Underwent Glaucoma Surgery. |
| Q38260300 | Recent proteomic advances in developmental, regeneration, and cancer governing signaling pathways |
| Q42489128 | Regulation of scleraxis transcriptional activity by serine phosphorylation. |
| Q40300781 | Retinoic Acid Inducible Gene 1 Protein (RIG1)-Like Receptor Pathway Is Required for Efficient Nuclear Reprogramming |
| Q33717766 | SDF-1 in Mammary Fibroblasts of Bovine with Mastitis Induces EMT and Inflammatory Response of Epithelial Cells |
| Q51759251 | Secreted Klotho Attenuates Inflammation-Associated Aortic Valve Fibrosis in Senescence-Accelerated Mice P1. |
| Q38266174 | SnoN as a novel negative regulator of TGF-β/Smad signaling: a target for tailoring organ fibrosis. |
| Q40323140 | TGFβ1 regulates Scleraxis expression in primary cardiac myofibroblasts by a Smad-independent mechanism. |
| Q34389744 | TM4SF5-mediated protein-protein networks and tumorigenic roles. |
| Q42101096 | The IκB kinase inhibitor ACHP strongly attenuates TGFβ1-induced myofibroblast formation and collagen synthesis |
| Q38524619 | The Role of PPAR Gamma in Systemic Sclerosis |
| Q42005066 | The liver is populated by a broad spectrum of markers for macrophages. In alcoholic hepatitis the macrophages are M1 and M2. |
| Q38572016 | The pro-fibrotic properties of transforming growth factor on human fibroblasts are counteracted by caffeic acid by inhibiting myofibroblast formation and collagen synthesis |
| Q26748151 | The progress of early growth response factor 1 and leukemia |
| Q39211384 | The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases |
| Q38687181 | The third path of tubulointerstitial fibrosis: aberrant endothelial secretome |
| Q46387801 | Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis |
| Q60044883 | Ultrasound point shear wave elastography of the pancreas: comparison of patients with type 1 diabetes and healthy volunteers - results from a pilot study |
| Q91971971 | Upregulation of Circular RNA CircNFIB Attenuates Cardiac Fibrosis by Sponging miR-433 |
| Q36717858 | Valproic acid suppresses collagen by selective regulation of Smads in conjunctival fibrosis |
| Q50663774 | Vascular Endothelial Growth Factor Prevents Endothelial-to-Mesenchymal Transition in Hypertrophy. |
| Q53624421 | [The epithelial-mesenchymal transition and fibrosis of the renal transplant]. |
| Q64109962 | circHIPK3 regulates lung fibroblast-to-myofibroblast transition by functioning as a competing endogenous RNA |
| Q60045578 | microRNA-29b mediates fibrotic induction of human xylosyltransferase-I in human dermal fibroblasts via the Sp1 pathway |
| Q64099042 | βklotho is essential for the anti-endothelial mesenchymal transition effects of N-acetyl-seryl-aspartyl-lysyl-proline |
Search more.